Аргинин.Ру - всё об аргинине  
В начало
Контакты
Рекламодателям
 


молекула L-arginine
молекула L-arginine

Нобелевские лауреаты 1998 года:

Ф.Ферчготт

Л.Игнарро

Ф.Мурад

аргинин по 1000 мг 90 капсул производства Solgar

Про аргинин:

Что такое аргинин?
Откуда берется аргинин?
Механизм действия.

Аргинин в медицине:

Сердечная недостаточн.
Стенокардия
Гипертония
Онкология (рак)
Геронтология (старение)
Атеросклероз
Травмы
Ожоги
Гормональный обмен
ВИЧ/СПИД

Где купить аргинин

аргинин по 1000 мг 90 капсул производства Solgar

Библиотека статей:




Deprecated: Methods with the same name as their class will not be constructors in a future version of PHP; SAPE_base has a deprecated constructor in /home/ih72672/public_html/arginine.ru/1152e72650d4093c1a42c7534a7d7797/sape.php on line 21

Deprecated: Methods with the same name as their class will not be constructors in a future version of PHP; SAPE_client has a deprecated constructor in /home/ih72672/public_html/arginine.ru/1152e72650d4093c1a42c7534a7d7797/sape.php on line 615

Deprecated: Methods with the same name as their class will not be constructors in a future version of PHP; SAPE_context has a deprecated constructor in /home/ih72672/public_html/arginine.ru/1152e72650d4093c1a42c7534a7d7797/sape.php on line 1177

Deprecated: Methods with the same name as their class will not be constructors in a future version of PHP; SAPE_articles has a deprecated constructor in /home/ih72672/public_html/arginine.ru/1152e72650d4093c1a42c7534a7d7797/sape.php on line 1529

Warning: Use of undefined constant _SAPE_USER - assumed '_SAPE_USER' (this will throw an Error in a future version of PHP) in /home/ih72672/public_html/arginine.ru/1152e72650d4093c1a42c7534a7d7797/sape.php on line 1090

Библиотека статей об аргинине. Июль 2004. En.

  1. Effect of short-term administration of high dose L-arginine on restenosis after percutaneous transluminal coronary angioplasty.
  2. Simultaneous determination of allantoin, choline and L-arginine in Rhizoma Dioscoreae by capillary electrophoresis.
  3. Diabetes mellitus in Tropical Chronic Pancreatitis Is Not Just a Secondary Type of Diabetes.
  4. The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution.
  5. Galanin-like peptide mRNA alterations in arcuate nucleus and neural lobe of streptozotocin-diabetic and obese zucker rats. Further evidence for leptin-dependent and independent regulation.
  6. Three novel cantharidin-related compounds from the Chinese blister beetle, Mylabris phalerata Pall.
  7. Evidence that estrogen suppresses rho-kinase function in the cerebral circulation in vivo.
  8. Hemodynamic and sympathoadrenal responses to mental stress during nitric oxide synthesis inhibition.
  9. Gastrointestinal nitric oxide generation in germ-free and conventional rats.
  10. Inverse metabolic engineering with phosphagen kinase systems improves the cellular energy state.
  11. Amino acid stabilization for cell-free protein synthesis by modification of the Escherichia coli genome.
  12. Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1.
  13. Effects of aminoguanidine and L-arginine methyl ester resuscitation following induction of fluid-percussion injury and severe controlled hemorrhagic shock in the rat brain.
  14. High glucose augments arginase activity and nitric oxide production in the renal cortex.
  15. Tumor protein p53-induced nuclear protein 1 (TP53INP1) in spontaneous chronic pancreatitis in the WBN/Kob rat: drug effects on its expression in the pancreas.
  16. The R172W mutation in peripherin/rds causes a cone-rod dystrophy in transgenic mice.
  17. Development of a whole-cell-based biosensor for detecting histamine as a model toxin.
  18. A method for connecting solution-phase enzyme activity assays with immobilized format analysis by mass spectrometry.
  19. L-arginine as a therapeutic tool in kidney disease.
  20. Nitric oxide and tubulointerstitial nephritides.
  21. Nitric oxide synthesis in the kidney: isoforms, biosynthesis, and functions in health.
  22. Metabolic effects of amino acid solutions infused for renal protection during therapy with radiolabelled somatostatin analogues.
  23. Simple non-invasive assessment of advanced glycation endproduct accumulation.
  24. The cofactor function of the N-terminal domain of tissue factor.
  25. Overlapping binding sites in protein phosphatase 2A for association with regulatory A and alpha-4 (mTap42) subunits.
  26. Two regions promote U11 small nuclear ribonucleoprotein particle binding to a retroviral splicing inhibitor element (negative regulator of splicing).
  27. Physical training may enhance beta-cell function in type 2 diabetes.
  28. Mutation of exposed hydrophobic amino acids to arginine to increase protein stability.
  29. Inhibition of growth hormone secretion in mild primary hyperparathyroidism.
  30. Impaired endothelial release of tissue-type plasminogen activator in patients with chronic kidney disease and hypertension.
  31. Red wine polyphenols induce EDHF-mediated relaxations in porcine coronary arteries through the redox-sensitive activation of the PI3-kinase/Akt pathway.
  32. Use of an arginine-restricted diet to slow progression of visual loss in patients with gyrate atrophy.
  33. Raloxifene lowers ischaemia susceptibility by increasing nitric oxide generation in the heart of ovariectomized rats in vivo.
  34. Vasopressin effects on the coronary circulation after a short ischemia in anesthetized goats: role of nitric oxide and prostanoids.
  35. Immunohistochemical localization of inducible and endothelial nitric oxide synthase in porcine ovaries and effects of NO on antrum formation and oocyte meiotic maturation.
  36. Effects of repeated restraint stress on hypothalamo-pituitary-adrenocortical function in vasopressin deficient Brattleboro rats.
  37. Small interacting peptides. Part II: Interaction of cyclohexapeptides with immobilised model peptides. Comparison of infrared investigations, principal components analysis and force field calculations.
  38. In vitro selection of state-specific peptide modulators of G protein signaling using mRNA display.
  39. Site-directed mutagenesis of human soluble calcium-activated nucleotidase 1 (hSCAN-1): identification of residues essential for enzyme activity and the Ca(2+)-induced conformational change.
  40. Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides.
  41. Inhibitor coordination interactions in the binuclear manganese cluster of arginase.
  42. Structural basis for Ca(2+)-induced activation of human PAD4.
  43. Absence of a reductase, NCB5OR, causes insulin-deficient diabetes.
  44. Insights into the oligomeric states, conformational changes, and helicase activities of SV40 large tumor antigen.
  45. Anchoring of surface proteins to the cell wall of Staphylococcus aureus.
  46. An exonic splicing enhancer offsets the atypical GU-rich 3' splice site of human apolipoprotein A-II exon 3.
  47. Ubiquitin is conjugated by membrane ubiquitin ligase to three sites, including the N terminus, in transmembrane region of mammalian 3-hydroxy-3-methylglutaryl coenzyme A reductase: implications for sterol-regulated enzyme degradation.
  48. Neutrophil elastase contributes to the development of ischemia-reperfusion-induced liver injury by decreasing endothelial production of prostacyclin in rats.
  49. Clinical features of hypertrophic cardiomyopathy caused by an Arg278Cys missense mutation in the cardiac troponin T gene.
  50. Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia.
  51. Protective effect of retinoic acid on interleukin-1 beta-induced cytotoxicity of pancreatic beta-cells.
  52. Serum cortisol as a predictive marker of the outcome in patients resuscitated after cardiopulmonary arrest.
  53. Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis.
  54. Nitric oxide from rat liver sinusoidal endothelial cells induces apoptosis in IFN gamma-sensitized CC531s colon carcinoma cells.
  55. Facilitative effect of a novel AVP fragment analog, NC-1900, on memory retention and recall in mice.
  56. Endothelin 1 and 3 enhance neuronal nitric oxide synthase activity through ETB receptors involving multiple signaling pathways in the rat anterior hypothalamus.
  57. Identification of a cDNA encoding DH, PBAN and other FXPRL neuropeptides from the tobacco hornworm, Manduca sexta, and expression associated with pupal diapause.
  58. The potent inducible nitric oxide synthase inhibitor ONO-1714 inhibits neuronal NOS and exerts antinociception in rats.
  59. A closer look at diagnosis in clinical dental practice: part 4.
  60. Identification of the Anabaena sp.
  61. Diabetes mellitus in Tropical Chronic Pancreatitis Is Not Just a Secondary Type of Diabetes.
  62. The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution.
  63. Galanin-like peptide mRNA alterations in arcuate nucleus and neural lobe of streptozotocin-diabetic and obese zucker rats. Further evidence for leptin-dependent and independent regulation.
  64. Three novel cantharidin-related compounds from the Chinese blister beetle, Mylabris phalerata Pall.
  65. Evidence that estrogen suppresses rho-kinase function in the cerebral circulation in vivo.
  66. Hemodynamic and sympathoadrenal responses to mental stress during nitric oxide synthesis inhibition.
  67. Gastrointestinal nitric oxide generation in germ-free and conventional rats.
  68. Inverse metabolic engineering with phosphagen kinase systems improves the cellular energy state.
  69. Amino acid stabilization for cell-free protein synthesis by modification of the Escherichia coli genome.
  70. Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1.
  71. Effects of aminoguanidine and L-arginine methyl ester resuscitation following induction of fluid-percussion injury and severe controlled hemorrhagic shock in the rat brain.
  72. High glucose augments arginase activity and nitric oxide production in the renal cortex.
  73. Tumor protein p53-induced nuclear protein 1 (TP53INP1) in spontaneous chronic pancreatitis in the WBN/Kob rat: drug effects on its expression in the pancreas.
  74. The R172W mutation in peripherin/rds causes a cone-rod dystrophy in transgenic mice.
  75. Development of a whole-cell-based biosensor for detecting histamine as a model toxin.
  76. A method for connecting solution-phase enzyme activity assays with immobilized format analysis by mass spectrometry.
  77. L-arginine as a therapeutic tool in kidney disease.
  78. Nitric oxide and tubulointerstitial nephritides.
  79. Nitric oxide synthesis in the kidney: isoforms, biosynthesis, and functions in health.
  80. Metabolic effects of amino acid solutions infused for renal protection during therapy with radiolabelled somatostatin analogues.
  81. Simple non-invasive assessment of advanced glycation endproduct accumulation.
  82. The cofactor function of the N-terminal domain of tissue factor.
  83. Overlapping binding sites in protein phosphatase 2A for association with regulatory A and alpha-4 (mTap42) subunits.
  84. Two regions promote U11 small nuclear ribonucleoprotein particle binding to a retroviral splicing inhibitor element (negative regulator of splicing).
  85. Physical training may enhance beta-cell function in type 2 diabetes.
  86. Mutation of exposed hydrophobic amino acids to arginine to increase protein stability.
  87. Inhibition of growth hormone secretion in mild primary hyperparathyroidism.
  88. Impaired endothelial release of tissue-type plasminogen activator in patients with chronic kidney disease and hypertension.
  89. Red wine polyphenols induce EDHF-mediated relaxations in porcine coronary arteries through the redox-sensitive activation of the PI3-kinase/Akt pathway.
  90. Use of an arginine-restricted diet to slow progression of visual loss in patients with gyrate atrophy.
  91. Raloxifene lowers ischaemia susceptibility by increasing nitric oxide generation in the heart of ovariectomized rats in vivo.
  92. Vasopressin effects on the coronary circulation after a short ischemia in anesthetized goats: role of nitric oxide and prostanoids.
  93. Immunohistochemical localization of inducible and endothelial nitric oxide synthase in porcine ovaries and effects of NO on antrum formation and oocyte meiotic maturation.
  94. Effects of repeated restraint stress on hypothalamo-pituitary-adrenocortical function in vasopressin deficient Brattleboro rats.
  95. Small interacting peptides. Part II: Interaction of cyclohexapeptides with immobilised model peptides. Comparison of infrared investigations, principal components analysis and force field calculations.
  96. In vitro selection of state-specific peptide modulators of G protein signaling using mRNA display.
  97. Site-directed mutagenesis of human soluble calcium-activated nucleotidase 1 (hSCAN-1): identification of residues essential for enzyme activity and the Ca(2+)-induced conformational change.
  98. Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides.
  99. Inhibitor coordination interactions in the binuclear manganese cluster of arginase.
  100. Structural basis for Ca(2+)-induced activation of human PAD4.
  101. Absence of a reductase, NCB5OR, causes insulin-deficient diabetes.
  102. Insights into the oligomeric states, conformational changes, and helicase activities of SV40 large tumor antigen.
  103. Anchoring of surface proteins to the cell wall of Staphylococcus aureus.
  104. An exonic splicing enhancer offsets the atypical GU-rich 3' splice site of human apolipoprotein A-II exon 3.
  105. Ubiquitin is conjugated by membrane ubiquitin ligase to three sites, including the N terminus, in transmembrane region of mammalian 3-hydroxy-3-methylglutaryl coenzyme A reductase: implications for sterol-regulated enzyme degradation.
  106. Neutrophil elastase contributes to the development of ischemia-reperfusion-induced liver injury by decreasing endothelial production of prostacyclin in rats.
  107. Clinical features of hypertrophic cardiomyopathy caused by an Arg278Cys missense mutation in the cardiac troponin T gene.
  108. Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia.
  109. Protective effect of retinoic acid on interleukin-1 beta-induced cytotoxicity of pancreatic beta-cells.
  110. Serum cortisol as a predictive marker of the outcome in patients resuscitated after cardiopulmonary arrest.
  111. Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis.
  112. Nitric oxide from rat liver sinusoidal endothelial cells induces apoptosis in IFN gamma-sensitized CC531s colon carcinoma cells.
  113. Facilitative effect of a novel AVP fragment analog, NC-1900, on memory retention and recall in mice.
  114. Endothelin 1 and 3 enhance neuronal nitric oxide synthase activity through ETB receptors involving multiple signaling pathways in the rat anterior hypothalamus.
  115. Identification of a cDNA encoding DH, PBAN and other FXPRL neuropeptides from the tobacco hornworm, Manduca sexta, and expression associated with pupal diapause.
  116. The potent inducible nitric oxide synthase inhibitor ONO-1714 inhibits neuronal NOS and exerts antinociception in rats.
  117. A closer look at diagnosis in clinical dental practice: part 4.
  118. Identification of the Anabaena sp.
  119. Postsynaptic production of nitric oxide implicated in long-term depression at the mature amphibian (Bufo marinus) neuromuscular junction.
  120. Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts.
  121. Mechanisms of arginine-vasopressin-induced Ca2+ oscillations in beta-cells (HIT-T15): a role for oscillating protein kinase C.
  122. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.
  123. Vascular biology in uremia: insights into novel mechanisms of vascular injury.
  124. Regulating a translational regulator: mechanisms cells use to control the activity of the fragile X mental retardation protein.
  125. The effect of divalent cations on neuronal nitric oxide synthase activity.
  126. Impaired endothelial function in never-treated hypertensive subjects carrying the Arg972 polymorphism in the insulin receptor substrate-1 gene.
  127. A form of Jansen's metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating parathyroid hormone (PTH)/PTH-related peptide receptor mutation.
  128. A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma.
  129. Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency.
  130. Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis.
  131. A molecular view on the interaction of the trojan peptide penetratin with the polar interface of lipid bilayers.
  132. Simulation of the interaction between ScyTx and small conductance calcium-activated potassium channel by docking and MM-PBSA.
  133. S-adenosylmethionine and its metabolite induce apoptosis in HepG2 cells: Role of protein phosphatase 1 and Bcl-x(S).
  134. Cation-pi interactions studied in a model coiled-coil peptide.
  135. The stimulation of arginine transport by TNFalpha in human endothelial cells depends on NF-kappaB activation.
  136. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease.
  137. Citrullination of self-proteins and autoimmunity.
  138. A polysaccharide carrier for immunostimulatory CpG DNAs to enhance cytokine secretion.
  139. L-arginine-induced experimental pancreatitis.
  140. KMUP-1, a xanthine derivative, induces relaxation of guinea-pig isolated trachea: the role of the epithelium, cyclic nucleotides and K+ channels.
  141. Inhibitory effects of L-arginine derivatives on endothelium-dependent vasorelaxing response to acetylcholine of the rat aorta.
  142. 5'-aminoimidazole-4-carboxyamide-ribonucleoside-activated glucose transport is not prevented by nitric oxide synthase inhibition in rat isolated skeletal muscle.
  143. The active site cysteine of arginine kinase: structural and functional analysis of partially active mutants.
  144. Crystal structure of the ascorbate peroxidase-salicylhydroxamic acid complex.
  145. Identification and characterization of Cu(2)O- and ZnO-binding polypeptides by Escherichia coli cell surface display: toward an understanding of metal oxide binding.
  146. Ubiquitination and degradation of neuronal nitric-oxide synthase in vitro: dimer stabilization protects the enzyme from proteolysis.
  147. Guanidinoacetate and creatine/creatinine levels in controls and patients with urea cycle defects.
  148. Guanidinoacetate methyltransferase deficiency: differences of creatine uptake in human brain and muscle.
  149. The role of carbon monoxide and nitric oxide in hyperosmolality-induced atrial natriuretic peptide release by hypothalamus in vitro.
  150. Temperature dependence of the thrombin-catalyzed proteolysis of prothrombin.
  151. Co-localization of neuronal nitric oxide synthase with arginine-vasotocin in the preoptic-hypothalamo-hypophyseal system of the teleost Oreochromis niloticus.
  152. Seasonal differences and protection by creatine or arginine pretreatment in ischemia of mammalian and molluscan neurons in vitro.
  153. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
  154. The hydrogen bonds between Arg423 and Glu472 and other key residues, Asp443, Ser477, and Pro489, are responsible for the formation and a different positioning of TNP-ATP and ATP within the nucleotide-binding site of Na(+)/K(+)-ATPase.
  155. Sequence-independent acylation of the vaccinia virus A-type inclusion protein.
  156. The crystal structure of human endonuclease VIII-like 1 (NEIL1) reveals a zincless finger motif required for glycosylase activity.
  157. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release.
  158. Long-term anaerobic survival of the opportunistic pathogen Pseudomonas aeruginosa via pyruvate fermentation.
  159. Acetylcholine-induced relaxation and hyperpolarization in small bovine adrenal cortical arteries: role of cytochrome P450 metabolites.
  160. Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury.
  161. Estrogen replacement suppresses stress-induced cardiovascular responses in ovariectomized rats.
  162. Endothelial NOS is main mediator for shear stress-dependent angiogenesis in skeletal muscle after prazosin administration.
  163. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder.
  164. Influence of electrical parameters in the iontophoretic delivery of a small peptide: in vitro studies using arginine-vasopressin as a model peptide.
  165. The effect of pretreatment with terpenes on transdermal iontophoretic delivery of arginine vasopressin.
  166. Association of p53 arginine polymorphism with skin cancer.
  167. The structure of bovine F1-ATPase inhibited by ADP and beryllium fluoride.
  168. Inhibition of melatonin-induced ascorbic acid and LHRH release by a nitric oxide synthase and cyclic GMP inhibitor.
  169. Spontaneous integration of transmembrane peptides into a bacterial magnetic particle membrane and its application to display of useful proteins.
  170. Absolute quantitation of proteins by a combination of acid hydrolysis and matrix-assisted laser desorption/ionization mass spectrometry.
  171. Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins.
  172. The unprecedented nos gene cluster of Wolinella succinogenes encodes a novel respiratory electron transfer pathway to cytochrome c nitrous oxide reductase.
  173. Analysis of morphological and functional maturation of neoislets generated in vitro from pancreatic ductal cells and their suitability for islet banking and transplantation.
  174. Correction of intraoperative coagulopathy in a patient with neurofibromatosis type I with intravenous desmopressin (DDAVP).
  175. Modification of endothelial cell functions by Hantaan virus infection: prolonged hyper-permeability induced by TNF-alpha of hantaan virus-infected endothelial cell monolayers.
  176. Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.
  177. Effect of the codon 72 polymorphism.
  178. The N-terminal 85 amino acids of the barley stripe mosaic virus gammab pathogenesis protein contain three zinc-binding motifs.
  179. CO exchange of the oxyferrous complexes of endothelial nitric-oxide synthase oxygenase domain in the presence of 4-amino-tetrahydrobiopterin.
  180. Importance of valine 567 in substrate recognition and oxidation by neuronal nitric oxide synthase.
  181. Endothelium- and nitric oxide-dependent vasorelaxing activities of gamma-butyrobetaine esters: possible link to the antiischemic activities of mildronate.
  182. The spread of cell death from impact damaged cartilage: lack of evidence for the role of nitric oxide and caspases.
  183. Nitric oxide sustains nuclear factor kappaB activation in cytokine-stimulated chondrocytes.
  184. Heme oxygenase modulates hepatic leukocyte sequestration via changes in sinusoidal tone in systemic inflammation in mice.
  185. The effect of an RGD-containing fusion protein CBD-RGD in promoting cellular adhesion.
  186. Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteries.
  187. Navigation within host tissues: Schistosoma mansoni and Trichobilharzia ocellata schistosomula respond to chemical gradients.
  188. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
  189. Unassisted refolding of urea-denatured arginine kinase from shrimp Feneropenaeus chinensis: evidence for two equilibrium intermediates in the refolding pathway.
  190. Loss of chondroitin 6-O-sulfotransferase-1 function results in severe human chondrodysplasia with progressive spinal involvement.
  191. Localization of transforming growth factors, TGFbeta1 and TGFbeta3, in hypothalamic magnocellular neurones and the neurohypophysis.
  192. Treacher Collins syndrome with craniosynostosis, choanal atresia, and esophageal regurgitation caused by a novel nonsense mutation in TCOF1.
  193. Structural changes in cerebral arteries following nitric oxide deprivation: a comparison between normotensive and hypertensive rats.
  194. Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice.
  195. Site-specific labelling with a metal chelator for protein-structure refinement.
  196. Enhanced expression of receptor for advanced glycation end products in chronic kidney disease.
  197. Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis.
  198. Transdermal delivery of desmopressin using a coated microneedle array patch system.
  199. Biochemical characterization of a low-affinity arginine permease from the parasite Trypanosoma cruzi.
  200. A novel missense mutation in the galactosyltransferase-I (B4GALT7) gene in a family exhibiting facioskeletal anomalies and Ehlers-Danlos syndrome resembling the progeroid type.
  201. A woman with postoperative hyponatremia related to desmopressin acetate.
  202. Oral administration of L-arginine decreases necrosis of the epigastric skin flap in the rat.
  203. Perioperative management of diabetes insipidus in children.
  204. Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta).
  205. Vasoconstriction in exercising skeletal muscles: a potential role for neuropeptide Y?Am J Physiol Heart Circ Physiol.
  206. DNA helix-stack switching as the basis for the design of versatile deoxyribosensors.
  207. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor.
  208. Proteolysis-independent regulation of the transcription factor Met4 by a single Lys 48-linked ubiquitin chain.
  209. Nitric oxide mediates ultrasound-induced hypoxia-inducible factor-1alpha activation and vascular endothelial growth factor-A expression in human osteoblasts.
  210. The equine herpesvirus 1 EICP27 protein enhances gene expression via an interaction with TATA box-binding protein.
  211. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
  212. Arginine vasopressin and adrenocorticotropin secretion in response to psychosocial stress is attenuated by ethanol in sons of alcohol-dependent fathers.
  213. Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen.
  214. In vitro activation of protein kinase C by beta-N-oxalyl-L-alpha,beta-diaminopropionic acid, the Lathyrus sativus neurotoxin.
  215. Involvement of increased arginase activity in impaired cavernous relaxation with aging in the rabbit.
  216. Accumulated endogenous nitric oxide synthase inhibitors in inhibiting urethral relaxation following estrogen supplementation in ovariectomized rabbits.
  217. Imidapril improves L-NAME-exacerbated nephrosclerosis with TGF-beta 1 inhibition in spontaneously hypertensive rats.
  218. Response to desmopressin of factors XI, X and V in patients with factor VIII deficiency and von Willebrand disease.
  219. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10.
  220. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons.
  221. Synergistic interaction between enalapril, L-arginine and tetrahydrobiopterin in smooth muscle cell apoptosis and aortic remodeling induction in SHR.
  222. Identification of Val117 and Arg372 as critical amino acid residues for the activity difference between human CYP2A6 and CYP2A13 in coumarin 7-hydroxylation.
  223. A new presenilin Alzheimer's disease case confirms the helical alignment of pathogenic mutations in transmembrane domain 5.
  224. Integrin alpha v beta 6 is an RGD-dependent receptor for coxsackievirus A9.
  225. Peptidase activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
  226. Signal transmission from the suprachiasmatic nucleus to the pineal gland via the paraventricular nucleus: analysed from arg-vasopressin peptide, rPer2 mRNA and AVP mRNA changes and pineal AA-NAT mRNA after the melatonin injection during light and dark periods.
  227. Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics.
  228. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis.
  229. Identification of a novel allele HLA-A*1113 in a Japanese donor.
  230. Modulations of shear stress-induced contractile responses and agonist-induced vasodilation in hypercholesterolemic rats.
  231. RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts.
  232. Hypophosphorylated ASF/SF2 binds TAP and is present in messenger ribonucleoproteins.
  233. Perinatal L-arginine and antioxidant supplements reduce adult blood pressure in spontaneously hypertensive rats.
  234. Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand.
  235. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
  236. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.
  237. Cellular aspects of allorecognition in the compound ascidian Botryllus schlosseri.
  238. Vasorelaxant effect of the aqueous extract of Ajuga iva in rat aorta.
  239. In vitro culture studies of Sutherlandia frutescens on human tumor cell lines.
  240. The dopamine precursor L-dihydroxyphenylalanine is transported by the amino acid transporters rBAT and LAT2 in renal cortex.
  241. Successful treatment of severe anaphylactic shock with vasopressin.
  242. Expression of VIP and/or PACAP receptor mRNA in peptide synthesizing cells within the suprachiasmatic nucleus of the rat and in its efferent target sites.
  243. PRMT3 is a ribosomal protein methyltransferase that affects the cellular levels of ribosomal subunits.
  244. Pressor responsiveness to intravenous quinpirole is blunted in malnourished, conscious rats: central vs.
  245. Apolipoprotein e structure and substrate and receptor-binding activities of triglyceride-rich human plasma lipoproteins in normo- and hypertriglyceridemia.
  246. Reduced endothelial nitric oxide synthase activity and concentration in fetal umbilical veins from maternal cigarette smokers.
  247. Myogenic reactivity is enhanced in rat radial uterine arteries in a model of maternal undernutrition.
  248. [The role of nitric oxide in trauma and infection]
  249. Mesenteric arterial relaxation to calcitonin gene-related peptide is increased during pregnancy and by sex steroid hormones.
  250. [Identification of signal sequences determining the specific nucleolar localization of fibrillarin in HeLa cells]
  251. Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-alpha/epsilon (PKCalpha/epsilon)-dependent cytoprotective signaling pathway and is inhibited by cyclosporin A.
  252. Renovascular hypertension in mice with brain-selective overexpression of AT1a receptors is buffered by increased nitric oxide production in the periphery.
  253. Effects of nitric oxide synthase inhibitor on decrease in peripheral arterial stiffness with acute low-intensity aerobic exercise.
  254. Control of myocardial oxygen consumption in transgenic mice overexpressing vascular eNOS.
  255. Inhibition of nicotinic acetylcholine receptors by apolipoprotein E-derived peptides in rat hippocampal slices.
  256. Lipopolysaccharide stimulates nitric oxide synthase-2 expression in murine skeletal muscle and C(2)C(12) myoblasts via Toll-like receptor-4 and c-Jun NH(2)-terminal kinase pathways.
  257. Role of calcium signaling in the activation of mitochondrial nitric oxide synthase and citric acid cycle.
  258. Biochemical enrichment and biophysical characterization of a taste receptor for L-arginine from the catfish, Ictalurus puntatus.
  259. Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome?
  260. Electrochemical detector for microchip electrophoresis of poly(dimethylsiloxane) with a three-dimensional adjustor.
  261. Dietary composition as a determinant of plasma asymmetric dimethylarginine in subjects with mild hypercholesterolemia.
  262. Nucleophilic and general acid catalysis at physiological pH by a designed miniature esterase.
  263. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
  264. Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma.
  265. INFgamma stimulates arginine transport through system y+L in human monocytes.
  266. Renal and hormonal effects of water deprivation in late-term pregnant rats.
  267. Perioperative systemic haemostatic agents.
  268. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA.
  269. Combined effects of benidipine and diltiazem in a rat model of experimental angina.
  270. The role of substrate-binding groups in the mechanism of aspartate-beta-semialdehyde dehydrogenase.
  271. Chemotactic response of Helicobacter pylori to human plasma and bile.
  272. Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium.
  273. A cascade of 24 histatins (histatin 3 fragments) in human saliva. Suggestions for a pre-secretory sequential cleavage pathway.
  274. Monitoring conformational rearrangements in the substrate-binding site of a membrane transport protein by mass spectrometry.
  275. Identification of the tRNA-binding protein Arc1p as a novel target of in vivo biotinylation in Saccharomyces cerevisiae.
  276. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
  277. Combined NO and PG inhibition augments alpha-adrenergic vasoconstriction in contracting human skeletal muscle.
  278. Endogenous polyamine levels in macrophages is sufficient to support growth of Toxoplasma gondii.
  279. Nitric oxide in health and disease of the respiratory system.
  280. Intermediates in the inactivation and unfolding of dimeric arginine kinase induced by GdnHCl.
  281. Side chain-side chain interactions of arginine with tyrosine and aspartic acid in Arg/Gly/Tyr-rich domains within plant glycine-rich RNA binding proteins.
  282. Heparin normalizes allergen-induced nitric oxide deficiency and airway hyperresponsiveness.
  283. Time course of nitric oxide production after endotoxin challenge in mice.
  284. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle.
  285. AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo.
  286. Extra-cellular superoxide promotes T cell expansion through inactivation of nitric oxide.
  287. Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease?